Apple Securities Litigation

March 15, 2024. Parties in the Apple securities matter (Northern District of California) agreed to settle for $490 million. Plaintiff alleged that Apple had made materially false and misleading statements about demand for the company’s iPhone XS, XS Max, and XR, and the strength of its business conditions in China. Professor Steven Feinstein of Babson College and […]

Johnson & Johnson Securities Litigation 

December 29, 2023. The Court in Johnson & Johnson Securities Litigation (District of New Jersey) certified a class of common stock investors. Plaintiff alleges that Defendants artificially inflated the price of Johnson & Johnson’s common stock by making false and misleading statements to conceal from investors that the Company’s talc products were contaminated with asbestos. […]

Grupo Televisa Securities Litigation 

April 20, 2023. The Parties agreed to and the Court approved a $95 million settlement in a class action lawsuit filed against Grupo Televisa. Plaintiffs alleged that Grupo Televisa paid bribes to Fédération Internationale de Football Association (“FIFA”) executives for World Cup broadcast rights. According to Plaintiffs, the concealed scheme artificially inflated the market price […]

Synchrony Financial Securities Litigation

April 12, 2023. The Parties agreed to and the Court approved a $34 million settlement in a class action securities case involving Synchrony Financial. Plaintiffs alleged that Synchrony misrepresented the quality of its loan portfolio and underwriting practices. Professor Steven Feinstein of Babson College and Crowninshield Financial Research provided expert analysis and testimony on market […]

Cardinal Health Securities Litigation 

April 4, 2023. The Parties agreed to and the Court approved a $109 million settlement in a class action securities litigation brought against Cardinal Health. Plaintiffs alleged that Cardinal failed to disclose inventory and supply chain issues at Cordis Corp., an operating unit the company acquired. Professor Steven Feinstein of Babson College and Crowninshield Financial […]

Inovio Pharmaceuticals Securities Litigation 

January 18, 2023. The Parties agreed to and the Court approved a $44 million settlement in a class action lawsuit filed against Inovio Pharmaceuticals. Plaintiffs alleged that the Company made misleading statements about its ability to quickly produce an effective Covid-19 vaccine. According to Plaintiffs, the misrepresentation inflated the Company’s stock price and caused investor […]

AmTrust Financial Services Securities Litigation

November 16, 2022. The Parties agreed to and the Court approved a $13 million settlement in a class action securities lawsuit involving AmTrust Financial Services. Plaintiffs alleged that the company mislead investors by telling them the that the Company’s preferred shares would continue to be listed on the New York Stock Exchange after a planned […]

EQT Corporation Securities Litigation

August 11, 2022. The Court in EQT Corporation Securities Litigation (Western District of Pennsylvania) certified a class of common stock investors. Plaintiffs allege that Defendants misled investors by stating that EQT’s acquisition of Rice Energy would yield billions of dollars in synergies. Professor Steven Feinstein of Babson College and Crowninshield Financial Research provided expert analysis and deposition testimony establishing […]

Merit Medical Securities Litigation

April 18, 2022. The Court approved Merit Medical’s $18.25 million payment to end a securities class action lawsuit that was brought against the company in the Central District of California. Plaintiffs alleged that Merit Medical misled investors about the company’s business and prospects; specifically, Merit Medical’s integration of two acquisitions was disastrous and the company’s […]

Jeld-Wen Securities Litigation

November 22, 2021. The Court in the Jeld-Wen securities matter (Eastern District of Virginia) approved a $40 million class action settlement and plan of allocation. Plaintiffs alleged that Jeld-Wen failed to disclose its intentional anticompetitive conduct that violated federal antitrust law. Professor Steven Feinstein of Babson College and Crowninshield Financial Research provided expert analysis and testimony on […]